Issue 20, 2022

Engineering a selective fluorescent sensor with a high signal-to-background ratio for microalbumin detection and imaging

Abstract

Abnormal concentrations of human serum albumin (HSA) are closely related to the occurrence of various diseases, such as liver cirrhosis and kidney disease. Thus, it is of great importance to monitor HSA in body fluids, especially microalbumin in urine. However, due to the interference of other proteins and the low-polar microenvironment, a high signal-to-background (S/B) ratio and selective detection of microalbumin are still a great challenge. To this end, we propose an innovative strategy based on the two-pronged effect of the twisted intramolecular charge transfer (TICT) and the excited state intramolecular proton transfer (ESIPT) mechanisms of flavonoid fluorophores, which is used to significantly improve the signal-to-background ratio of the HSA selective fluorescent sensor. As a proof of strategy demonstration, an HSA specific binding flavonoid molecule (FNE3) was developed by combining chemical design and screening approaches. Due to binding to the new binding site (subdomain IB) of HSA in molecular simulations, FNE3 exhibits a remarkable 1042-fold fluorescence response for HSA but only a 1.8-fold for BSA, which has been the highest S/B ratio among HSA probes so far, enabling highly sensitive differential detection of HSA from other proteins. Moreover, FNE3 is superior to the commercial BCG method in the rapid and sensitive detection of microalbumin in clinical urine samples, and the quantitative detection results were in good agreement with the clinical data. With the excellent performance of FNE3, we further applied it to the selective detection of HSA-specifically bound drugs via a competitive displacement mechanism, and successfully realized the selective visualization of anti-inflammatory drugs diflunisal (DIF) in urine and living cells for the first time. This study indicates that FNE3 may offer a promising tool for the future HSA associated clinical testing and noninvasive pharmaceutical screening.

Graphical abstract: Engineering a selective fluorescent sensor with a high signal-to-background ratio for microalbumin detection and imaging

Supplementary files

Article information

Article type
Research Article
Submitted
04 máj 2022
Accepted
29 aug 2022
First published
31 aug 2022

Mater. Chem. Front., 2022,6, 3084-3093

Engineering a selective fluorescent sensor with a high signal-to-background ratio for microalbumin detection and imaging

L. Su, F. Yang, W. Li, H. Li, C. Wang, Q. Wang and L. Yuan, Mater. Chem. Front., 2022, 6, 3084 DOI: 10.1039/D2QM00392A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements